4//SEC Filing
Khayal Tamer I 4
Accession 0000950170-24-126397
CIK 0001756262other
Filed
Nov 12, 7:00 PM ET
Accepted
Nov 13, 4:30 PM ET
Size
8.7 KB
Accession
0000950170-24-126397
Insider Transaction Report
Form 4
Khayal Tamer I
Chief Commercial Officer
Transactions
- Exercise/Conversion
Common Stock
2024-11-11$38.46/sh+1,458$56,075→ 22,301 total - Sale
Common Stock
2024-11-11$90.04/sh−1,458$131,278→ 20,843 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-11-11−1,458→ 5,834 totalExercise: $38.46Exp: 2031-02-24→ Common Stock (1,458 underlying)
Footnotes (3)
- [F1]The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $90.00 to $90.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F3]The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 24, 2025.
Documents
Issuer
TransMedics Group, Inc.
CIK 0001756262
Entity typeother
Related Parties
1- filerCIK 0001430462
Filing Metadata
- Form type
- 4
- Filed
- Nov 12, 7:00 PM ET
- Accepted
- Nov 13, 4:30 PM ET
- Size
- 8.7 KB